Aims and Scope
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global
biomedical researchers across the cancer sciences. The journal considers submissions from all oncologic specialties, including, but not limited
to, the following areas:
Molecular biology • cellular biology • molecular genetics • genomics • immunology • epigenetics • metabolic studies • proteomics
• cytopathology • carcinogenesis • drug discovery and delivery
Clinical cancer research
Translational research • clinical trials • chemotherapy • radiation therapy • surgical therapy • clinical observations • clinical guidelines • genetic
consultation • ethical considerations
Behavioral science • psychosocial studies • screening • nutrition • epidemiology and prevention • community outreach
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited
editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented
in the paper.
We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made
widely accessible as quickly as possible. Cancer Medicine publishes papers submitted directly to the journal and those referred from a
select group of prestigious journals published by Wiley-Blackwell.
Cancer Medicine is a Wiley Open Access journal, one of a new series of peer-reviewed titles publishing quality research with speed and
efﬁ ciency. For further information visit the Wiley Open Access website at http://www.wileyopenaccess.com.
Open Access and Copyright
All articles published by Cancer Medicine are fully open access: immediately freely available to read, download and share. All articles accepted
from 14 August 2012 are published under the terms of the Creative Commons Attribution License. All articles accepted before this date
were published under a Creative Commons Attribution Non-Commercial License. The Creative Commons Attribution License permits
use, distribution and reproduction in any medium, provided the original work is properly cited and allows the commercial use of published
articles. Copyright on any research article in a journal published by Cancer Medicine is retained by the author(s). Authors grant Wiley a
license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as
long as its integrity is maintained and its original authors, citation details and publisher are identiﬁ ed. Further information about open access
license and copyright can be found at http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
Purchasing Print Reprints
Print reprints of Wiley Open Access articles can be purchased from firstname.lastname@example.org.
The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal;
the views and opinions expressed do not necessarily reﬂ ect those of the Publisher and Editors, neither does the publication of advertisements
constitute any endorsements by the Publisher and Editors of the products advertised.
Wiley Open Access articles posted to repositories or websites are without warranty from Wiley of any kind, either express or implied, including,
but not limited to, warranties of merchantability, ﬁ tness for a particular purpose, or non-infringement. To the fullest extent permitted by law
Wiley disclaims all liability for any loss or damage arising out of, or in connection with, the use of or inability to use the content.
CAM4_7_3_prelims.indd 1CAM4_7_3_prelims.indd 1 3/1/2018 12:03:34 PM3/1/2018 12:03:34 PM